July 2020
First publication summarizing interim results of ProCore’s Post Marketing Placebo Controlled Double Blind Clinical Study
First publication summarizing interim results of ProCore’s Post Marketing Placebo Controlled Double Blind Clinical Study for RegenoGel and RegenoGel OSP, demonstrating superiority of RegenoGel and RegenoGel OSP treatment over placebo for patients suffering from moderate to severe knee osteoarthritis.